Israel - English - Ministry of Health

baxter healthcare distribution ltd., israel - calcium chloride dihydrate; disodium phosphate dihydrate; magnesium chloride hexahydrate; potassium chloride; sodium chloride; sodium hydrogen carbonate - solution for heamodialysis/haemofiltration - disodium phosphate dihydrate 0.225 g/l; potassium chloride 0.314 g/l; sodium chloride 6.44 g/l; magnesium chloride hexahydrate 2.44 g/l; calcium chloride dihydrate 3.68 g/l; sodium hydrogen carbonate 2.92 g/l - combinations - phoxilium is used for crrt (continuous renal replacement therapy) in critically ill patients with arf (acute renal failure) when ph and kalaemia have been restored to normal and when the patients need phosphate supplementation for loss of phosphate in the ultrafiltrate or to the dialysate during crrt. phoxilium may also be used in cases of drug poisoning or intoxications when the poisons are dialysable or pass through the membrane.phoxilium is indicated for use in patients with normal kalaemia and normal or hypophosphataemia.

New Zealand - English - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - vancomycin hydrochloride 500mg (cont. nmt 0.025% edetic acid (= nmt 0.032% disodium edetate)) - powder for injection - 500 mg - active: vancomycin hydrochloride 500mg (cont. nmt 0.025% edetic acid (= nmt 0.032% disodium edetate))

New Zealand - English - Medsafe (Medicines Safety Authority)

novartis new zealand ltd - lodoxamide trometamol 1.78 mg/ml equivalent to 1 mg/ml lodoxamide - eye drops, solution - 1 mg/ml - active: lodoxamide trometamol 1.78 mg/ml equivalent to 1 mg/ml lodoxamide excipient: benzalkonium chloride citric acid monohydrate disodium edetate dihydrate hydrochloric acid hypromellose mannitol purified water sodium citrate dihydrate sodium hydroxide tyloxapol - lomide eye drops 0.1% are indicated in the treatment of non-infectious allergic conjunctivitis (vernal conjunctivitis, giant papillary conjunctivitis and seasonal allergic conjunctivitis). the aetiologic factors are unknown, but common airborne allergens and contact lenses have been implicated. lodoxamide trometamol may be effective against other ocular diseases where type-i, ige-mediated hypersensitivity (or mast cells) play a major role in the inflammatory process. prophylactic use of lomide eye drops will assist in minimising the allergic symptoms associated with seasonal allergic conjunctivitis.

New Zealand - English - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - piperacillin monohydrate 2 g (as piperacillin sodium 2.085g);  ;  ; tazobactam 250mg; piperacillin monohydrate 2 g (as piperacillin sodium 2.085g); tazobactam 250mg (as tazobactam sodium 0.2683 g) - powder for injection - 2g/250mg - active: piperacillin monohydrate 2 g (as piperacillin sodium 2.085g)     tazobactam 250mg piperacillin monohydrate 2 g (as piperacillin sodium 2.085g) tazobactam 250mg (as tazobactam sodium 0.2683 g) excipient: citric acid monohydrate disodium edetate dihydrate sodium bicarbonate - indicated for the treatment of the following systemic and/or local bacterial infections in which susceptible organisms have been detected or are suspected: 1. lower respiratory tract infections 2. urinary tract infections (complicated and uncomplicated) 3. intra-abdominal infections 4. skin and skin structure infections 5. bacterial septicaemia 6. gynaecological infections 7. bacterial infections in neutropenic patients. full therapeutic doses of tazocin ef plus an aminoglycoside should be used. 8. bone and joint infections 9. polymicrobic infections: tazocin ef is indicated for polymicrobic infections including those where aerobic and anaerobic organisms are suspected (intra-abdominal, skin and skin structure, upper and lower respiratory tract, gynaecological). children under the age of 12 years in hospitalised children aged 2 to 12 years, tazocin ef is indicated for the treatment of serious intra-abdominal infections.

New Zealand - English - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - piperacillin monohydrate 4 g (as piperacillin sodium 4.17g);  ;  ; tazobactam 500mg;  ; piperacillin monohydrate 4 g (as piperacillin sodium 4.17g); tazobactam 500mg (as tazobactam sodium 0.5366 g) - powder for injection - 4g/500mg - active: piperacillin monohydrate 4 g (as piperacillin sodium 4.17g)     tazobactam 500mg   piperacillin monohydrate 4 g (as piperacillin sodium 4.17g) tazobactam 500mg (as tazobactam sodium 0.5366 g) excipient: citric acid monohydrate disodium edetate dihydrate sodium bicarbonate - indicated for the treatment of the following systemic and/or local bacterial infections in which susceptible organisms have been detected or are suspected: 1. lower respiratory tract infections 2. urinary tract infections (complicated and uncomplicated) 3. intra-abdominal infections 4. skin and skin structure infections 5. bacterial septicaemia 6. gynaecological infections 7. bacterial infections in neutropenic patients. full therapeutic doses of tazocin ef plus an aminoglycoside should be used. 8. bone and joint infections 9. polymicrobic infections: tazocin ef is indicated for polymicrobic infections including those where aerobic and anaerobic organisms are suspected (intra-abdominal, skin and skin structure, upper and lower respiratory tract, gynaecological). children under the age of 12 years in hospitalised children aged 2 to 12 years, tazocin ef is indicated for the treatment of serious intra-abdominal infections.

Ireland - English - HPRA (Health Products Regulatory Authority)

casen-recordati s.l. - sodium phosphate dibasic dodecahydrate; sodium phosphate dibasic dihydrate - oral solution - 24.4/10.8 gram(s) - osmotically acting laxatives

Ireland - English - HPRA (Health Products Regulatory Authority)

elanco gmbh - dicyclanil - pour-on suspension - 12.5 milligram(s)/millilitre - dicyclanil

Australia - English - Department of Health (Therapeutic Goods Administration)

abbvie pty ltd - flurbiprofen sodium dihydrate, quantity: 0.3 mg/ml - eye drops, solution - excipient ingredients: polyvinyl alcohol; potassium chloride; sodium chloride; sodium citrate dihydrate; citric acid monohydrate; disodium edetate; thiomersal; sodium hydroxide; hydrochloric acid; purified water - for the inhibition of intraoperative miosis.

Jordan - English - JFDA (Jordan Food & Drug Administration - المؤسسة العامة للغذاء والدواء)

شـركــة فيلادلـفيا لــصناعـــة الأدويـــــــة - philadelphia pharmaceuticals - sodium dihydrogen phosphate 2h2o 10 % w/v, disodium hydrogen phosphate dihydrate 3.98 % w/v - 10% w/v, 3.98% w/v

Australia - English - Department of Health (Therapeutic Goods Administration)

astrazeneca pty ltd - chadox1-s, quantity: 100000000000 vp/ml - injection, solution - excipient ingredients: histidine; magnesium chloride hexahydrate; sucrose; disodium edetate; polysorbate 80; sodium chloride; histidine hydrochloride monohydrate; ethanol absolute; water for injections - vaxzevria has provisional approval for the indication:,active immunisation of individuals greater than or equal to 18 years old for the prevention of coronavirus disease 2019 (covid-19) caused by sars-cov-2.,the use of this vaccine should be in accordance with official recommendations.,the decision has been made on the basis of short term efficacy and safety data. continued approval is dependent upon the evidence of longer-term efficacy and safety from ongoing clinical trials and post-market assessment.